The treatment of primary brain tumors, particularly gliomas, is undergoing a profound revolution. This transformation is largely driven by a shift away from the traditional "one-size-fits-all" approach toward a model of precision medicine. Central to this change are the concepts of targeted cancer treatment and advanced neuro-oncology therapeutics. This powerful combination...